CNR2 and colitis: Intense CB2 immunoreactivity in acute group was evidenced in mild [70.801±7.042 vs 53.301±1.278 (×103); p<0.01] and moderate colitis [58.86±2.46 vs 53.30±1.27 (×103); p<0.05], in comparison with controls but not in the severe cases.